Market Need Specialty drug spend is the fastest-growing healthcare expense, driving plan sponsors to seek objective, actionable guidance. Archimedes offers independent specialty drug management for health plans, TPAs, employers, and labor groups across the United States with no conflicted relationships with PBMs or specialty pharmacies. This positions you as a trusted partner to control costs while preserving access to valuable therapies; a pilot program can demonstrate savings and waste reduction.

Target Buyers Primary buyers are plan sponsors such as health plans, TPAs, employers, and labor groups, with decision makers including CFOs, benefits leaders, and procurement contacts who care about both economics and clinical outcomes. Archimedes differentiates by independence from PBMs and conflicted incentives, which resonates with sponsors seeking objective analyses; outreach should emphasize transparency, measurable savings, and practical decision support.

Clear Value The value proposition centers on full visibility into the economics and clinical performance of specialty drug programs to inform decisions, minimize waste, and reduce clinically ineffective therapies. The company combines analytics, technology, and pragmatism to deliver actionable guidance and measurable ROI. Sales approach could include a diagnostic assessment and a road map showing potential cost containment and program optimization.

Growth Angles With ongoing growth in specialty drug spend in the United States, opportunities exist to partner with health plans, TPAs, employers, and labor groups nationwide. Cross sell beyond pharmacy to include medical benefit insights, and highlight the independence from PBMs as a competitive differentiator. Leverage industry events, associations, and digital channels to reach plan sponsors and present data driven value propositions.

Credibility Edge Archimedes is a tech enabled analytics provider with an emphasis on independence from conflicted financial relationships, building trust with plan sponsors wary of vendor incentives. Use case ready capabilities include economic and clinical performance visibility and waste reduction. Propose a discovery session to map current workflows, identify gaps, and quantify potential savings to tailor a compelling ROI narrative.